These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37827996)

  • 1. Chatbot-supported psychoeducation in adult attention-deficit hyperactivity disorder: randomised controlled trial.
    Selaskowski B; Reiland M; Schulze M; Aslan B; Kannen K; Wiebe A; Wallbaum T; Boll S; Lux S; Philipsen A; Braun N
    BJPsych Open; 2023 Oct; 9(6):e192. PubMed ID: 37827996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile app-based chatbot to deliver cognitive behavioral therapy and psychoeducation for adults with attention deficit: A development and feasibility/usability study.
    Jang S; Kim JJ; Kim SJ; Hong J; Kim S; Kim E
    Int J Med Inform; 2021 Jun; 150():104440. PubMed ID: 33799055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smartphone-assisted psychoeducation in adult attention-deficit/hyperactivity disorder: A randomized controlled trial.
    Selaskowski B; Steffens M; Schulze M; Lingen M; Aslan B; Rosen H; Kannen K; Wiebe A; Wallbaum T; Boll S; Lux S; Philipsen A; Braun N
    Psychiatry Res; 2022 Nov; 317():114802. PubMed ID: 36041353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.
    Lopez PL; Torrente FM; Ciapponi A; Lischinsky AG; Cetkovich-Bakmas M; Rojas JI; Romano M; Manes FF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010840. PubMed ID: 29566425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial.
    Haugan AJ; Sund AM; Young S; Thomsen PH; Lydersen S; Nøvik TS
    BMC Psychiatry; 2022 Jun; 22(1):375. PubMed ID: 35655149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Elmose Andersen M; Skoog M; Joost Hansen S; Simonsen E; Pedersen N; Tendal B; Callesen HE; Faltinsen E; Gluud C
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008223. PubMed ID: 31222721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.
    Svanborg P; Thernlund G; Gustafsson PA; Hägglöf B; Poole L; Kadesjö B
    Eur Child Adolesc Psychiatry; 2009 Apr; 18(4):240-9. PubMed ID: 19156355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mindfulness and psychoeducation on working memory in adult ADHD: A randomised, controlled fMRI study.
    Bachmann K; Lam AP; Sörös P; Kanat M; Hoxhaj E; Matthies S; Feige B; Müller H; Özyurt J; Thiel CM; Philipsen A
    Behav Res Ther; 2018 Jul; 106():47-56. PubMed ID: 29758392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial.
    Janssen L; Kan CC; Carpentier PJ; Sizoo B; Hepark S; Schellekens MPJ; Donders ART; Buitelaar JK; Speckens AEM
    Psychol Med; 2019 Jan; 49(1):55-65. PubMed ID: 29486807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
    JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Zwi M; Jones H; Thorgaard C; York A; Dennis JA
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003018. PubMed ID: 22161373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What adults with ADHD want to know: A Delphi consensus study on the psychoeducational needs of experts by experience.
    Seery C; Wrigley M; O'Riordan F; Kilbride K; Bramham J
    Health Expect; 2022 Oct; 25(5):2593-2602. PubMed ID: 35999687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducational groups versus waitlist in treatment of attention-deficit hyperactivity/impulsivity disorder (ADHD) in adults: a protocol for a pilot randomized waitlist-controlled multicenter trial.
    Vaag JR; Lara-Cabrera ML; Hjemdal O; Gjervan B; Torgersen T
    Pilot Feasibility Stud; 2019; 5():17. PubMed ID: 30693097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes in an Adult Attention Deficit Hyperactivity Disorder Clinic With a Focus on Executive Functioning and Sluggish Cognitive Tempo.
    Gaur S; Pallanti S
    Cureus; 2020 Aug; 12(8):e9814. PubMed ID: 32953325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.